Navigation Links
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Date:9/11/2007

re to determine the maximum tolerated dose (MTD) to be used in Phase 2 studies as well as to determine the safety, anti-tumor, and pharmacokinetic and pharmacodynamic profiles of TPI 287. In October 2006, the Company reached the MTD of its second Phase 1 trial. The Company is headquartered in Boulder, Colorado, with offices in New Jersey and New York.

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small and mid-cap companies. Crystal Research Associates' unique and novel product, the Executive Informational Overview(R) (EIO(R)), is free of investment ratings, target prices, and forward-looking financial models. The EIO(R) presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO(R) details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, audited financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, Delray Beach, Montreal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of forty seven thousand five hundred dollars for its services in creating this report, for updates, and for printing costs

Forward-Looking Safe Harbor Statement

Statements in this news release regarding the potential effectiveness of TPI 287 in treating a broad spectrum of cancers and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates,"
'/>"/>

SOURCE Crystal Research Associates, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Government To Clamp Down On Crystal Meth
2. Insulin Crystals Holds Promise In Diabetes research
3. Does Aspirin Crystallize?
4. Cellulose Nanocrystal Research Paves the Way for Newer Vaccines, Computer Inks
5. Human Membranes Crystal Structure may Help Tailor Asthma Drugs
6. Kidney Stones - Interesting New Research implicates bacteria as its cause
7. Stem cell research- now Nobel Laureates join the debate
8. Researchers urge caution in using ear tube surgery
9. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
10. Spouses and other partners lower blood pressure says new research
11. Researchers Scale to assess the Severity of Epilepsy in Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Dec. 4 The Editorial Advisory and ...gazine today announced Allergan, Inc. (NYSE: ....R. Bard, Inc. (NYSE: BCR ) as its February 201... and educational use. ,, "The committee chose A...its flagship drug Botox and other products as well...
(Date:12/4/2009)... that muscle cells grown in the lab can restore an... work, performed in dogs and rats, might ultimatel...ric reflux and fecal incontinence. , This techni...e the bands of muscle that separate the major sect...reas can cause gastrointestinal esophageal reflux ...
(Date:12/4/2009)... phenomenon that was started by people that were l...tal work in the US, Canada, and other countries. I...e have found that Mexican Dental Vacation is a gre... (PRWEB) December 4, 2009 -- Af...an Dental Vacation is seeing their best year ever,...
(Date:12/4/2009)...ic Effort but Points out Potential Risk if America...re Reform ,, NEW YORK, Dec. 4 /PRNewswire-USN... today published a Perspective opinion piece addr...dlener, M.D., president, Children,s Health Fund an...ess and Professor of Clinical Population & Fam...
(Date:12/4/2009)...to take breast cancer drug, study finds , ...ut side effects are a major reason why only 6 perc...er are willing to take the drug tamoxifen to preve...rt to inform women about the risks and benefits of...gan Comprehensive Cancer Center created a decision...
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2
...ccording to a review that was published in the Fri...m supplements to kids does not reduce their risk o... the research, 90% of the maximum bone mass is got...osis. The results of 19 studies, on about 2,90...
...tudies indicate that ‘Fingolimod’, a new oral drug...ght prove effective.// The new study has su... be effective in helping patients with relapsing m...ll to the drug, it could offer patients with MS th...
...erobic exercise has the potential to reduce the ri...study by US researchers says. //Lead researcher Dr...er Research Center studied 102 men and 100 women a...diets. Men who exercised showed less cancer-cell g...
...verseas-trained nurses will be given ?5,000 to ret...alth minister Andy Kerr said that the Scottish Exe...on this plan.// This plan will be directed at...urses who are trained outside Europe and are not l...
...he Government Doctors’ Association of Tamil Nadu h...ate medical colleges in the State. // Accordi...e monetary burden of the State neither will it exe... into the deficiency of staff in non-clinical post...
...egardless of gender, generation or income group, m...or a workout versus a gym and an exercise physiolo...gery, a leading center for sports medicine, thinks... they enjoy it,” according to Polly de Mille, exer...
Other Medicine News:Health News:An Experimental New Drug Might Be Effective In Treating MS 2Health News:Dance Your Way to a Better Body 2Health News:Dance Your Way to a Better Body 3
(Date:12/4/2009)...wire/ -- Amber Pharmacy announced today that it re...on for Health Care, Inc. (ACHC) for specialized ph...cy has provided comprehensive pharmacy care progra...lized conditions. Amber Pharmacy is one of the lea... They work with over 170 transplant programs and m...
(Date:12/4/2009)...PRNewswire/ -- Shared Imaging, LLC, an independent...e programs for hospitals and healthcare providers,...Commission,s Accreditation for Ambulatory Health C...l of approval for quality and safety in patient ca...r its mobile MRI and PET/CT services. Mobile servi...
(Date:12/4/2009)...rugs often stored in tin cans and car trunks ,...oday, the senior advocacy group RetireSafe urged t...compassed in SA 2793. RetireSafe President Thair P...ent is poised to open our borders, allowing our sa...lth to be endangered. We could soon be getting dr...
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Drug shrinks lung cancer tumors in mice 61091 1Drug shrinks lung cancer tumors in mice 61091 2Drug shrinks lung cancer tumors in mice 61091 3Carnegie Mellon researchers to develop probes to study cellular GPS 10681 1Carnegie Mellon researchers to develop probes to study cellular GPS 10681 2Healthy babies by the numbers 10678 1Healthy babies by the numbers 10678 2
...Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced ...nc. (Ortho-McNeil) initiated under their partnersh...97, a novel oral drug candidate discovered by Aren...c receptor (GDIR) for the treatment of type 2 diab...s the potential to stimulate insulin release in re...
... 14 Eisai Corporation of North,America today anno...FDA) has,approved LUSEDRA(TM) (fospropofol disodiu...nt for monitored anesthesia care (MAC) sedation in...ic procedures. , In the approval, the FDA re...d in the administration of general anesthesia and ...
Other Medicine Technology:Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 3Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 4FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 2FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 3FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 4
Harms Corneal Utility Forceps, Colibri Style
Demarres Chalazion Forceps - 16 mm
Gradle Cilia Forceps
Hunt Chalazion Forceps
Medicine Products: